Streetbeat News

Analyst Ratings

AMD

CAMT

COHR

LITE

MRVL

MTSI

NVDA

ON

BofA analyst Vivek Arya has made several changes to his ratings and price targets for semiconductor companies. He upgraded Camtek Ltd (CAMT) to Buy and raised the price target to $50 from $30. He downgraded Coherent Corp (COHR) and MACOM Technology Solutions Holdings, Inc (MTSI) to Neutral, raising their price targets to $55 and $72 respectively. Lumentum Holdings Inc (LITE) was downgraded to Underperform with a price target of $50. Arya also raised price targets for Nvidia Corp (NVDA), Marvell Technology, Inc (MRVL), and ON Semiconductor Corp (ON). However, he reduced Advanced Micro Devices, Inc's (AMD) price target to $130 from $135.

Portfolio Pulse from Anusuya Lahiri

July 18, 2023 | 8:00 pm

AGCO

AGCO (NYSE:AGCO) has received a mix of bullish and indifferent ratings from analysts in the last quarter. The average 12-month price target for AGCO has increased by 6.37% from $147.60 to $157.00, according to 6 analysts. No bearish ratings were observed.

Portfolio Pulse from Benzinga Insights

July 18, 2023 | 8:00 pm

PXD

Pioneer Natural Resources (NYSE:PXD) has received various analyst ratings in the last quarter, with 4 bullish, 3 somewhat bullish, 1 indifferent, and 2 somewhat bearish. The average 12-month price target for the company, according to 10 analysts, is $265.7, a 2.1% decrease from the previous average of $271.40.

Portfolio Pulse from Benzinga Insights

July 18, 2023 | 8:00 pm

CMPS

COMPASS Pathways (NASDAQ:CMPS) has shared positive results from an open-label Phase 2 trial assessing its synthetic psilocybin COMP360 alongside SSRIs for Treatment-Resistant Depression (TRD). The findings show a positive correlation in terms of safety and efficacy. The company is also conducting a large randomized, controlled, double-blind Phase 3 trial of COMP360 therapy for TRD, with first topline results expected in summer 2024.

Portfolio Pulse from Lara Goldstein

July 18, 2023 | 7:54 pm

WEC

WEC Energy Group Inc. (NYSE:WEC) is currently trading at $88.34, after a 1.32% decrease. Over the past month, the stock fell by 1.88%, and in the past year, by 8.02%. The company's price-to-earnings (P/E) ratio is lower than the aggregate P/E ratio of the Multi-Utilities industry, which could indicate that the stock is undervalued or that shareholders do not expect future growth.

Portfolio Pulse from Benzinga Insights

July 18, 2023 | 7:45 pm

ECL

RBC Capital Markets analyst Ashish Sabadra has reiterated an Outperform rating on Ecolab Inc. (ECL) with a price target of $213. Sabadra expects Ecolab to return to pre-pandemic levels by FY25 with double-digit EPS growth and margin recovery. The analyst anticipates a 9.4% y/y revenue growth in 2Q23, above the consensus of 7.3%, driven by pricing gains and volume growth in all segments. However, concerns about raw material inflation persist. ECL shares are currently trading higher by 0.43% to $188.34.

Portfolio Pulse from Nabaparna Bhattacharya

July 18, 2023 | 7:33 pm

UBER

Uber's stock price is expected to rise following Roth MKM's decision to increase its price target for the company from $46 to $59.

Portfolio Pulse from Benzinga Newsdesk

July 18, 2023 | 7:30 pm

EW

Edwards Lifesciences Inc. (NYSE:EW) is currently trading at $91.89, after a 0.82% drop. The stock has fallen by 0.02% over the past month and by 9.44% over the past year. The company's P/E ratio is lower than the aggregate P/E of 154.8 of the Health Care Equipment & Supplies industry, which could indicate that the stock is undervalued or that shareholders do not expect future growth.

Portfolio Pulse from Benzinga Insights

July 18, 2023 | 7:30 pm

OXY

Stephens analyst Mike Scialla has lowered the price target of Occidental Petroleum Corp (NYSE:OXY) to $69 from $72, citing a decline in projected realized natural gas and NGL prices and a higher expected LOE. The Q2 FY23 cash flow per share (CFPS) estimate has been reduced to $2.59, 10% below consensus. The Q2 EBITDA estimate has also been reduced by 13% to $3.22 billion. Morgan Stanley has also reduced OXY's price target to $60 from $63.

Portfolio Pulse from Lekha Gupta

July 18, 2023 | 7:19 pm

UNH

UnitedHealth Group Incorporated (NYSE:UNH) shares are moving higher after Bernstein analyst Lance Wilkes upgraded the stock from Market Perform to Outperform and raised the price target from $595 to $603. The upgrade follows the company's solid Q2 results, with earnings per share 3% higher than expected. Wilkes predicts long term growth for the company due to a shift to government managed care and value based care.

Portfolio Pulse from Ryan Gustafson

July 18, 2023 | 7:16 pm